 BOSTON, Aug. 23, 2022 GLOBE NEWSWIRE -- Sensei Biotherapeutics, Inc. NASDAQ: SNSE, an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer, today announced that Company management will participate in the following investor conferences in September 2022: 